$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Trial efficacy data of sotoracib in the treatment of lung cancer? _ Kanghule
2025-10-19 11:44:20
Check Details
Trial data of capmatinib in the treatment of lung cancer? _ Kanghule
2025-10-19 11:44:20
Check Details
How long does it take to see the effect of taking ceritinib? _ Kanghule
2025-10-19 11:44:20
Check Details
What are the indications, usage and dosage, adverse reactions and efficacy of amivantamab?
2025-10-19 11:44:20
Check Details
What are the clinical trial effects of amivantamab in the treatment of lung cancer?
2025-10-19 11:44:20
Check Details
Can crizotinib eliminate tumors?
2025-10-19 11:44:20
Check Details
What are the efficacy, effects and side effects of Adagrasib?
2025-10-19 11:44:20
Check Details
What are the usage, dosage, dosage adjustments and precautions of Gefitinib?
2025-10-19 11:44:20
Check Details
Can I take sotorasibu (AMG510) with G12D mutation?
2025-10-19 11:44:20
Check Details
What is the correct usage, dosage and dosage adjustment of Crizotinib?
2025-10-19 11:44:20
Check Details
What is the effect of osimertinib (AZD9291) on lung cancer brain metastasis? _ Kanghule
2025-10-19 11:44:20
Check Details
What are the efficacy, functions and side effects of mobocertinib?
2025-10-19 11:44:20
Check Details
1
2
...
10182
10183
10184
10185
10186
10187
10188
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
2
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
3
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
4
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
5
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
6
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
7
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
8
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
9
A Precision FGFR Inhibitor for Cholangiocarcinoma
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: